These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20225412)

  • 1. [Remodeling of the left atrium and atrial fibrillation - neurohumoral consequences].
    Łoboz-Grudzień K
    Kardiol Pol; 2010 Jan; 68(1):55-6. PubMed ID: 20225412
    [No Abstract]   [Full Text] [Related]  

  • 2. Left atrial size and function after spontaneous cardioversion of atrial fibrillation and their relation to N-terminal atrial natriuretic peptide.
    Mattioli AV; Bonatti S; Bonetti L; Borella P; Mattioli G
    Am J Cardiol; 2003 Jun; 91(12):1478-81, A8. PubMed ID: 12804740
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in plasma natriuretic peptide levels in patients with atrial fibrillation after cardioversion.
    Wozakowska-Kaplon B
    Int J Cardiol; 2010 Oct; 144(3):436-7. PubMed ID: 19556018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-induced natriuretic peptide secretion predicts cardioversion outcome in patients with persistent atrial fibrillation: discordant ANP and B-type natriuretic peptide response to exercise testing.
    Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1203-9. PubMed ID: 20487352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion.
    Bartkowiak R; Wozakowska-Kapłon B; Janiszewska G
    Kardiol Pol; 2010 Jan; 68(1):48-54. PubMed ID: 20131188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation.
    Nedios S; Seewöster T; Lip GH; Husser D; Hindricks G; Bollmann A; Kornej J
    Int J Cardiol; 2016 Jan; 203():621-3. PubMed ID: 26580343
    [No Abstract]   [Full Text] [Related]  

  • 7. ANP and BNP in atrial fibrillation before and after cardioversion--and their relationship to cardiac volume and function.
    Therkelsen SK; Groenning BA; Kjaer A; Svendsen JH; Boje Jensen G
    Int J Cardiol; 2008 Jul; 127(3):396-9. PubMed ID: 17628724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of the size of the left atrium for the success of cardioversion in atrial fibrillation].
    Carstens V; Neufang KF; Behrenbeck DW
    Med Welt; 1981 Jul; 32(29):1146-8. PubMed ID: 7266350
    [No Abstract]   [Full Text] [Related]  

  • 9. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Janion M
    Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of the relation between the size of the left atrium and atrial tachyfibrillation].
    Murín J
    Bratisl Lek Listy; 1983 Sep; 80(3):316-21. PubMed ID: 6627060
    [No Abstract]   [Full Text] [Related]  

  • 11. No correlation between atrial natriuretic peptide concentrations and echocardiographic measurements of left atrial size or left ventricular size and function in patients with persistent atrial fibrillation.
    Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S110-4. PubMed ID: 15683475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma concentrations of atrial natriuretic peptides after cardioversion of chronic atrial fibrillation.
    Arakawa M; Miwa H; Kambara K; Ohno M; Kagawa K; Nishigaki K; Ito Y; Kawada T; Hirakawa S
    Am J Cardiol; 1992 Aug; 70(4):550-2. PubMed ID: 1386493
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysfunction of the left atrium after cardioversion of atrial fibrillation.
    Omran H; Jung W; Lüderitz B
    Am J Cardiol; 1998 Sep; 82(6):837. PubMed ID: 9761107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is spontaneous echo contrast in the left atrium a risk factor for an embolic event?].
    Zuppiroli A; Petrillo C
    G Ital Cardiol; 1995 Apr; 25(4):517-26. PubMed ID: 7642057
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of electrical cardioversion in patients with chronic auricular fibrillation and the size of the left atrium evaluated by ultrasonocardiography].
    Trojnar R; Rymar B; Kutarski A; Wysokiński A; Kedra AW
    Wiad Lek; 1982 Nov; 35(21):1305-9. PubMed ID: 6219499
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
    Bakowski D; Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation.
    Chang IC; Chen LY; Chong JP; Austin E; Quay CN; Gong L; Mark Richards A; Ling LH
    Int J Cardiol; 2015 Jun; 188():10-2. PubMed ID: 25880572
    [No Abstract]   [Full Text] [Related]  

  • 18. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation.
    Ellinor PT; Low AF; Patton KK; Shea MA; Macrae CA
    J Am Coll Cardiol; 2005 Jan; 45(1):82-6. PubMed ID: 15629379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of remodeling in atrial fibrillation: a positive double-negative?
    George Wyse D
    J Cardiovasc Electrophysiol; 2004 May; 15(5):513-4. PubMed ID: 15149417
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.